Victory Capital Management Inc Ligand Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

  • $153 Billion
  • Q3 2025

A detailed history of Victory Capital Management Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 254,805 shares of LGND stock, worth $51.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
254,805
Previous 32,809 676.63%
Holding current value
$51.2 Million
Previous $3.73 Million 1110.4%
% of portfolio
0.03%
Previous 0.0%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$112.56 - $177.14 $25 Million - $39.3 Million
221,996 Added 676.63%
254,805 $45.1 Million
Q2 2025

Aug 13, 2025
BUY
$96.67 - $118.22 $496,013 - $606,586
5,131 Added 18.54%
32,809 $3.73 Million
Q1 2025

May 02, 2025
BUY
$105.14 - $122.23 $1.41 Million - $1.64 Million
13,456 Added 94.61%
27,678 $2.91 Million
Q4 2024

Feb 06, 2025
BUY
$99.95 - $129.9 $19,990 - $25,980
200 Added 1.43%
14,222 $1.52 Million
Q3 2024

Nov 05, 2024
BUY
$82.7 - $110.11 $513,236 - $683,342
6,206 Added 79.4%
14,022 $1.4 Million
Q2 2024

Aug 05, 2024
SELL
$68.53 - $87.91 $82,921 - $106,371
-1,210 Reduced 13.41%
7,816 $658,000
Q1 2024

May 03, 2024
SELL
$68.64 - $89.2 $848,321 - $1.1 Million
-12,359 Reduced 57.79%
9,026 $659,000
Q4 2023

Feb 05, 2024
BUY
$49.57 - $72.63 $197,090 - $288,776
3,976 Added 22.84%
21,385 $1.53 Million
Q3 2023

Nov 06, 2023
BUY
$58.86 - $72.67 $450,396 - $556,070
7,652 Added 78.43%
17,409 $1.04 Million
Q2 2023

Jul 27, 2023
BUY
$69.53 - $79.33 $479,757 - $547,377
6,900 Added 241.51%
9,757 $703,000
Q1 2023

May 02, 2023
SELL
$65.67 - $77.08 $49,383 - $57,964
-752 Reduced 20.84%
2,857 $210,000
Q4 2022

Feb 10, 2023
BUY
$61.72 - $96.74 $987 - $1,547
16 Added 0.45%
3,609 $241,000
Q4 2022

Feb 09, 2023
SELL
$61.72 - $96.74 $1.47 Million - $2.3 Million
-23,752 Reduced 86.86%
3,593 $240,000
Q3 2022

Nov 02, 2022
SELL
$0.01 - $107.56 $32 - $354,195
-3,293 Reduced 10.75%
27,345 $2.35 Million
Q2 2022

Aug 01, 2022
SELL
$74.52 - $117.06 $240,774 - $378,220
-3,231 Reduced 9.54%
30,638 $2.73 Million
Q1 2022

May 04, 2022
BUY
$94.99 - $151.56 $691,812 - $1.1 Million
7,283 Added 27.39%
33,869 $3.43 Million
Q4 2021

Feb 07, 2022
SELL
$127.69 - $165.85 $859,098 - $1.12 Million
-6,728 Reduced 20.2%
26,586 $4.11 Million
Q3 2021

Nov 02, 2021
SELL
$102.33 - $144.73 $151,448 - $214,200
-1,480 Reduced 4.25%
33,314 $4.64 Million
Q2 2021

Aug 03, 2021
SELL
$113.03 - $155.64 $436,747 - $601,392
-3,864 Reduced 10.0%
34,794 $4.57 Million
Q1 2021

May 04, 2021
BUY
$99.52 - $215.83 $3.26 Million - $7.07 Million
32,749 Added 554.22%
38,658 $5.89 Million
Q4 2020

Feb 01, 2021
SELL
$80.55 - $106.05 $20.3 Million - $26.7 Million
-251,782 Reduced 97.71%
5,909 $588,000
Q3 2020

Nov 09, 2020
SELL
$89.56 - $126.72 $1.36 Million - $1.92 Million
-15,140 Reduced 5.55%
257,691 $24.6 Million
Q2 2020

Aug 07, 2020
SELL
$68.28 - $123.65 $1.46 Million - $2.64 Million
-21,367 Reduced 7.26%
272,831 $30.5 Million
Q1 2020

May 04, 2020
SELL
$63.37 - $107.88 $515,514 - $877,603
-8,135 Reduced 2.69%
294,198 $21.4 Million
Q4 2019

Feb 06, 2020
BUY
$96.94 - $113.59 $355,963 - $417,102
3,672 Added 1.23%
302,333 $31.5 Million
Q4 2019

Feb 04, 2020
SELL
$96.94 - $113.59 $10.6 Million - $12.4 Million
-109,092 Reduced 26.75%
298,661 $26.2 Million
Q3 2019

Nov 12, 2019
SELL
$86.25 - $120.16 $15.4 Million - $21.5 Million
-179,082 Reduced 30.52%
407,753 $40.6 Million
Q2 2019

Aug 15, 2019
SELL
$107.38 - $129.34 $7.39 Million - $8.91 Million
-68,855 Reduced 10.5%
586,835 $67 Million
Q1 2019

May 03, 2019
BUY
$105.93 - $142.47 $19.7 Million - $26.5 Million
186,090 Added 39.63%
655,690 $82.4 Million
Q4 2018

Feb 05, 2019
BUY
$128.36 - $272.13 $4.04 Million - $8.57 Million
31,475 Added 7.18%
469,600 $63.7 Million
Q3 2018

Nov 01, 2018
SELL
$211.18 - $274.49 $21 Million - $27.2 Million
-99,230 Reduced 18.47%
438,125 $120 Million
Q2 2018

Aug 02, 2018
BUY
$150.77 - $207.98 $4.08 Million - $5.63 Million
27,075 Added 5.31%
537,355 $111 Million
Q1 2018

May 04, 2018
SELL
$138.63 - $182.62 $2.43 Million - $3.2 Million
-17,532 Reduced 3.32%
510,280 $84.3 Million
Q4 2017

Feb 01, 2018
SELL
$128.36 - $147.04 $17.1 Million - $19.6 Million
-133,458 Reduced 20.18%
527,812 $72.3 Million
Q3 2017

Oct 27, 2017
SELL
$120.91 - $137.94 $2.14 Million - $2.44 Million
-17,675 Reduced 2.6%
661,270 $90 Million
Q2 2017

Aug 07, 2017
BUY
N/A
678,945
678,945 $82.4 Million

Others Institutions Holding LGND

# of Institutions
343
Shares Held
20.5M
Call Options Held
19K
Put Options Held
11.5K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.39B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email